MK6096 in Patients with Primary Insomnia (011)

• Research type

  Research Study

• Full title

  A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, 2-Period Adaptive Crossover Polysomnography Study to Evaluate the Safety and Efficacy of MK6096 in Patients with Primary Insomnia

• IRAS ID

  32910

• Contact name

  Paul Robinson

• Contact email

  paul_robinson@merck.com

• Sponsor organisation

  Merck Sharp & Dohme Limited

• Eudract number

  2009-015773-12

• ISRCTN Number

  Eudract

• REC name

  London - Central Research Ethics Committee

• REC reference

  09/H0718/64

• Date of REC Opinion

  8 Jan 2010

• REC opinion

  Further Information Favourable Opinion